Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ribosome peptidyl transferase center (PTC)–nascent peptide chain complex is the catalytic core of the ribosome responsible for synthesizing proteins by forming peptide bonds. Located within the large ribosomal subunit (50S in bacteria, 60S in eukaryotes), the PTC acts as a ribozyme that precisely positions the peptidyl-tRNA and aminoacyl-tRNA for catalysis (Steitz & Moore, 2003). As the nascent peptide chain grows, it traverses the ribosomal exit tunnel, where its sequence can interact with the ribosome to regulate translation or respond to small-molecule drugs (Wilson, 2014). This complex is a major target for diverse classes of antibiotics, such as macrolides, oxazolidinones, and lincosamides, which obstruct the exit tunnel or the PTC itself to halt bacterial growth (Beringer & Rodnina, 2007). Furthermore, the PTC-NC complex is a target for nonsense suppression therapies, like ataluren, which aim to treat genetic disorders by allowing the ribosome to read through premature stop codons (Peltz et al., 2013). Therapeutic development focuses on maximizing selectivity for bacterial or specific mutant complexes to avoid interfering with host mitochondrial or cytoplasmic translation. The structural dynamics of the nascent chain within the tunnel also influence cotranslational protein folding and the recruitment of chaperones. Resistance to drugs targeting this complex often arises through mutations in ribosomal RNA or the presence of ribosomal protection proteins.
Inhibition of peptide bond formation, steric hindrance of the nascent peptide exit tunnel, and modulation of translational read-through at premature stop codons.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosome peptidyl transferase center–nascent peptide chain complex (PTC-NC complex).